Molecular interaction of PCB153 to human serum albumin: Insights from spectroscopic and molecular modeling studies

Journal of Hazardous Materials

Volumn 248-249, Issue 1, 2013, Pages 313-321

  Han, Chao ^a   Fang, Senbiao ^a   Cao, Huiming ^a   Lu, Yan ^a   Ma, Yaqiong ^a   Wei, Dongfeng ^b   Xie, Xiaoyun ^a   Liu, Xiaohua ^a   Li, Xin ^c   Fei, Dongqing ^a   Zhao, Chunyan ^a  

^a LANZHOU UNIVERSITY   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Fluorescence; Human serum albumin (HSA); Molecular docking; Molecular dynamics; Polychlorinated biphenyls (PCBs)

Indexed keywords

BINDING ENERGY; BODY FLUIDS; CHEMICAL STABILITY; FLUORESCENCE; FREE ENERGY; HYDROGEN BONDS; HYDROPHOBICITY; MOLECULAR MODELING; ORGANIC POLLUTANTS; POLYCHLORINATED BIPHENYLS; THERMOANALYSIS; TOXICITY;

BINDING MODES; BIOLOGICAL TOXICITY; HUMAN SERUM ALBUMIN; HUMAN SERUM ALBUMINS; MOLECULAR DOCKING; MOLECULAR MODELING STUDIES; POLYCHLORINATED BIPHENYL; POTENTIAL HAZARDS; REPRESENTATIVE COMPOUND; SUBDOMAIN;

MOLECULAR DYNAMICS;

HUMAN SERUM ALBUMIN; POLYCHLORINATED BIPHENYL;

CHEMICAL BINDING; CHLORINE; EXPERIMENTAL STUDY; FLUORESCENCE; HOMINID; HYDROPHOBICITY; MOLECULAR ANALYSIS; ORGANIC POLLUTANT; PCB; PROTEIN; SERUM; TOXICOLOGY;

ARTICLE; CONFORMATIONAL TRANSITION; FLUORESCENCE ANALYSIS; HEMODYNAMICS; HUMAN; HYDROPHOBICITY; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MODEL; SPECTROSCOPY;

EID: 84873645549     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2012.12.056     Document Type: Article

References (40)

1. Unsworth J.F., Dorans H. Thermodynamic data for dioxins from molecular modelling computations: prediction of equilibrium isomer composition. Chemosphere 1993, 27:351-358.
2. Kavlock R.J., Daston G.P., DeRosa C., Fenner-Crisp P., Gray L.E., Kaattari S., Lucier G., Luster M., Mac M.J., Maczka C., Miller R., Moore J., Rolland R., Scott G., Sheehan D.M., Sinks T., Tilson H.A. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ. Health Perspect. 1996, 104:715-740.
3. Wehrmeier A., Lenoir D., Schramm L.W., Zimmermann R., Hahn K., Henkelmann B., Kettup A. Patterns of isomers of chlorinated dibenzo-p-dioxins as tool for elucidation of thermal formation mechanisms. Chemosphere 1998, 36:2775-2801.
4. Giesy J.P., Kannan K. Dioxin-like and non-dioxin-like toxic effects of polychlorinated biphenyls (PCBs): implications for risk assessment. Crit. Rev. Toxicol. 1998, 28:511-569.
5. Sánchez E., Fernández S.M., López-Aparicio P., Recio M.N., Pérez-Albarsanz M.A. Selective fatty acid release from intracellular phospholipids caused by PCBs in rat renal tubular cell cultures. Chem. Biol. Interact. 2000, 125:117-131.
6. w) of all PCDF congeners by density functional theory. J. Mol. Struct-theochem. 2005, 755:137-145.
7. V.A.McFarland, J.U.Clarke. Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congenerspecific analysis. Environ. Health Perspect. 1989, 81:225-239.
8. Wu B., Zhang Y., Kong J., Zhang X.X., Cheng S.P. In silico predication of nuclear hormone receptors for organic pollutants by homology modeling and molecular docking. Toxicol. Lett. 2009, 191:69-73.
9. Zolese G., Falcioni G., Bertoli E., Galeazzi R., Wozniak M., Wypych Z., Gratton E., Ambrosini A. Steady-state and time resolved fluorescence of albumins interacting with N-oleylethanolamine, a component of the endogenous N-acylethanolamines. Proteins 2000, 40:39-48.
10. Hu Y.J., Liu Y., Xiao X.H. Investigation of the interaction between berberine and human serum albumin. Biomacromolecules 2009, 10:517-521.
11. Curry S., Mandelkow H., Brick P., Franks N. Crystal structure of human serum albumin complexed with monounsaturated and polyunsaturated fatty acid. Nat. Struct. Biol. 1998, 5:827-835.
12. Fehske K.J., Mullar W.E., Wollart U. The location of drug binding sites in human serum albumin. Biochem. Pharmacol. 1981, 30:687-692.
13. Khan S.N., Islam B., Yennamalli R., Sultan A., Subbarao N., Khan A.U. Interaction of mitoxantrone with human serum albumin: spectroscopic and molecular modeling studies. Eur. J. Pharm. Sci. 2008, 35:371-382.
14. Deeb O., Rosales-Hernández M.C., Gómez-Castro C., Garduño-Juárez R., Correa-Basurto J. Exploration of human serum albumin binding sites by docking and molecular dynamics flexible ligand-protein interactions. Biopolymers 2010, 93:161-170.
15. Herve F., Urien S., Albengres E., Duche J.C., Tillement.J.P. Drug binding in plasma: a summary of recent trends in the study of drug and hormone binding. Clin. Pharmacokinet. 1994, 26:44-58.
16. Liu H., Bao W., Ding H.J., Jang J.C., Zou G.L. Binding modes of flavones to human serum albumin: insights from experimental and computational studies. J. Phys. Chem. B 2010, 114:12938-12947.
17. Purcell M., Neault J.F., Malonga H., Arakawa H., Carpentier R., Tajmir-Riahi H.A. Interactions of atrazine and 2,4-D with human serum albumin studied by gel and capillary electrophoresis, and FTIR spectroscopy. BBA-Proteins Proteom. 2001, 1548:129-138.
18. Patel S., Datta A. Steady state and time-resolved fluorescence investigation of the specific binding of two chlorin derivatives with human serum albumin. J. Phys. Chem. B 2007, 111:10557-10562.
19. Xie X.Y., Wang X.R., Xu X.M., Sun H.J., Chen X.G. Investigation of the interaction between endocrine disruptor bisphenol A and human serum albumin. Chemosphere 2010, 80:1075-1080.
20. Saquib Q., Al-Khedhairy A.A., Siddiqui M.A., Roy A.S., Dasgupta S., Musarrat J. Preferential binding of insecticide phorate with sub-domain IIA of human serum albumin induces protein damage and its toxicological significance. Food Chem. Toxicol. 2011, 49:1787-1795.
21. Fujiwara S., Amisaki T. Identification of high affinity fatty acid binding sites on human serum albumin by MM-PBSA method. Biophys. J. 2008, 94:95-103.
22. Quevedo M.A., Ribone S.R., Moroni G.N., Brinon M.C. Binding to human serum albumin of zidovudine (AZT) and novel AZT derivatives. Experimental and theoretical analyses. Bioorg. Med. Chem. 2008, 16:2779-2790.
23. Sudhamalla B., Gokara M., Ahalawat N., Amooru D.G., Subramanyam R. Molecular dynamics simulation and binding studies of β-sitosterol with human serum albumin and its biological relevance. J. Phys. Chem. B 2010, 114:9054-9062.
24. Safe S. Polychlorinated-biphenyls (PCBs)-environmental-impact, biochemical and toxic responses, and implications for risk assessment. Crit. Rev. Toxicol. 1994, 24:87-149.
25. Rahman M.H., Maruyama T., Okada T., Yamasaki K., Otagiri M. Study of interaction of carprofen and its enantiomers with human serum albumin-I. Stereoselective site-to-site displacement of carprofen by ibuprofen. Biochem. Pharmacol. 1993, 46:1721-1731.
26. Petitpas I., Bhattacharya A.A., Twine S., East M., Curry S. Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I. J. Biol. Chem. 2001, 276:22804-22809.
27. Anderson A.C., O'Neil R.H., Surti T.S., Stroud R.M. Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking. Chem. Biol. 2001, 8:445-457.
28. Sherman W., Day T., Jacobson M.P., Friesner R.A., Farid R. Novel procedure for modeling ligand/receptor induced fit effects. J. Med. Chem. 2006, 49:534-553.
29. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., Olson A.J. Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 1998, 19:1639-1662.
30. D.A. Case, T.A. Darden, T.E. Cheatham, C.L. Simmerling, J. Wang, R.E.Duke, R.Luo, R.C.Walker, W.Zhang, K.M.Merz, B.Roberts, B.Wang, S.Hayik, A.Roitberg, G.Seabra, I.Kolossvai, K.F.Wong, F.Paesani, J.Vanicek, J.Liu, X.Wu, S.R.Brozell, T.Steinbrecher, H.Gohlke, Q.Cai, X.Ye, J.Wang, M.-J.Hsieh, G.Cui, D.R.Roe, D.H.Mathews, M.G.Seetin, C.Sagui, V.Babin, T.Luchko, S.Gusarov, A.Kovalenko, P.A.Kollman. AMBER 11. University of California, San Francisco, 2010.
31. Wang J., Wolf R.M., Caldwell J.W., Kollman P.A., Case D.A. Development and testing of a general AMBER force field. J. Comput. Chem. 2004, 25:1157-1174.
32. Kollman P.A., Massova I., Reyes C., Kuhn B., Huo S.H., Chong L., Lee M., Lee T., Duan Y., Wang W., Donini O., Cieplak P., Srinivasan J., Case D.A., Cheatham T.E. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc. Chem. Res. 2000, 33:889-897.
33. Lakowicz J.R. Principles of Fluorescence Spectroscopy 2006, Springer, New York. 3rd ed.
34. Gao H., Lei L., Liu J., Qin K., Chen X., Hu Z. The study on the interaction between human serum albumin and a new reagent with antitumour activity by spectrophotometric methods. J. Photochem. Photobiol. A 2004, 167:213-221.
35. Ross P.D., Subramanian S. Thermodynamics of steroid binding to the human glucocorticoid receptor. Biochemistry 1981, 20:3096-3102.
36. Mallick A., Haldar B., Chattopadhyay N. Spectroscopic investigation on the interaction of ICT probe 3-acetyl-4-oxo-6,7-dihydro-12H indolo-[2,3-a] quinolizine with serum albumins. J. Phys. Chem. B 2005, 109:14683-14690.
37. Pandey R.K., Constantine S., Tsuchida T., Zheng G., Medforth C.J., Aoudia M., Kozyrev A.N., Rodgers M.A.J., Kato H., Smith K.M., Dougherty T.J. Synthesis, photophysical properties, in vivo photosensitizing efficacy, and human serum albumin binding properties of some novel bacteriochlorins. J. Med. Chem. 1997, 40:2770-2779.
38. Consuelo Jiménez M., Miranda M.A., Vayá I. Triplet excited states as chiral reporters for the binding of drugs to transport proteins. J. Am. Chem. Soc. 2005, 127:10134-10135.
39. Sułkowska A., Maciazek-Jurczyk M., Bojko B., Równicka J., Zubik-Skupień I., Temba E., Pentak D., Sułkowski W.W. Competitive binding of phenylbutazone and colchicines to serum albumin in multidrug therapy: a spectroscopic study. J. Mol. Struct. 2008, 881:97-106.
40. Berhanu W.M., Masunov A.E. Molecular dynamic simulation of wildtype and mutants of the polymorphic amyloid NNQNTF segments of elk prion: structural stability and thermodynamic of association. Biopolymers 2011, 95:573-590.